Work

Supplementary Figure 2: Dinaciclib induces S-phase accumulation and reduces G2/M-phase accumulation from A Cyclin-Dependent Kinase Inhibitor, Dinaciclib, Impairs Homologous Recombination and Sensitizes Multiple Myeloma Cells to PARP Inhibition

Year: 2023

Type: supplementary-materials

Abstract: (A, B) H929 cells were treated as indicated for 24 h and cell-cycle distribution assessed by propidium iodide (PI) staining as described in Figure 5.

DOI: 10.1158/1535-7163.22503490

Authors: David A. Alagpulinsa, Srinivas Ayyadevara, Shmuel Yaccoby, Robert J. Shmookler Reis

Language: English

Topic: PARP inhibition in cancer therapy

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: gold

OpenAlex ID: W4362527068

Cites:

Cited by:

Related to: 10